PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. HOOD
8. DFTX
9. USO
10. RGNX

Go back to PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)
(NASDAQ: RYTM) Delayed: 98.51 +1.72 (1.78%)
Previous Close $96.79    52 Week High $ 
Open $97.80    52 Week Low $ 
Day High $99.81    P/E N/A 
Day Low $97.44    EPS $ 
Volume 491,374